Yu-Chien Cheng, MD
Endocrinology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Cheng’s office at (408) 972-3000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A154935 · Current
Licensed to practise in California · since 2018 · expires 2027-05-31 · Rosalind Franklin University, the Chicago Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$184,017
Pharmacies billed $184,017 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 975) in 2024. At or below the middle of the specialty; the typical endocrinology clinician is at 0%.
671 generic and 215 brand-name prescriptions · $184,017 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Forteo | 73 | $101,940 | $1,396 |
| Humalog Kwikpen U-100 | 23 | $9,658 | $420 |
| Humalog | 28 | $6,460 | $231 |
| Testosterone | 39 | $5,370 | $138 |
| Insulin Glargine-Yfgn | 46 | $5,086 | $111 |
See all 20 drugs
| Forteo | 73 | $101,940 | $1,396 |
| Humalog Kwikpen U-100 | 23 | $9,658 | $420 |
| Humalog | 28 | $6,460 | $231 |
| Testosterone | 39 | $5,370 | $138 |
| Insulin Glargine-Yfgn | 46 | $5,086 | $111 |
| Methimazole | 219 | $4,308 | $20 |
| Hydrocortisone | 45 | $2,990 | $66 |
| Levothyroxine | 126 | $2,311 | $18 |
| Armour Thyroid | 19 | $1,945 | $102 |
| Cinacalcet | 20 | $1,473 | $74 |
| Ultra-Fine Nano Pen Needle | 31 | $980 | $32 |
| Cabergoline | 21 | $912 | $43 |
| Testosterone Cypionate | 13 | $882 | $68 |
| Alendronate | 76 | $750 | $10 |
| Risedronate | 18 | $328 | $18 |
| Veo Insulin | 11 | $284 | $26 |
| Veo Insulin | 11 | $275 | $25 |
| Hydrochlorothiazide | 19 | $225 | $12 |
| Metformin Hcl Er | 11 | $103 | $9 |
| Dexamethasone | 12 | $69 | $6 |
Year by year
| 2024 | 975 | 276 | 0% (0) | 22% | $184,017 |
| 2023 | 873 | 227 | 0% (0) | 28% | $235,073 |
| 2022 | 732 | 217 | 0% (0) | 28% | $278,950 |
| 2021 | 759 | 223 | 0% (0) | 32% | $292,802 |
| 2020 | 442 | 163 | 0% (0) | 33% | $133,174 |
| 2019 | 284 | 85 | 0% (0) | None | $71,837 |
| 2018 | 198 | 53 | 0% (0) | 38% | $31,894 |
| 2017 | 106 | 23 | 0% (0) | 51% | $32,245 |
| 2016 | 116 | 32 | 0% (0) | None | $9,758 |
| 2015 | 167 | 46 | 0% (0) | 23% | $8,785 |
| 2014 | 145 | 36 | None | 19% | $8,273 |
| 2013 | 15 | None | 0% (0) | None | $545 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 17 drugs
| Forteo | 51 | $118,913 | $2,332 |
| Baqsimi | 24 | $14,612 | $609 |
| Humalog Kwikpen U-100 | 29 | $10,023 | $346 |
| Humalog | 32 | $9,873 | $309 |
| Diazoxide | 11 | $7,720 | $702 |
| Testosterone | 30 | $5,180 | $173 |
| Methimazole | 195 | $3,498 | $18 |
| Lantus Solostar | 17 | $2,787 | $164 |
| Levothyroxine | 108 | $2,735 | $25 |
| Hydrocortisone | 27 | $2,521 | $93 |
| Insulin Glargine-Yfgn | 18 | $1,938 | $108 |
| Armour Thyroid | 13 | $1,282 | $99 |
| Cinacalcet | 25 | $1,114 | $45 |
| Cabergoline | 20 | $956 | $48 |
| Ultra-Fine Nano Pen Needle | 29 | $826 | $28 |
| Ultra-Fine Short Pen Needle | 12 | $409 | $34 |
| Alendronate | 37 | $372 | $10 |
2022: 16 drugs
| Forteo | 50 | $192,248 | $3,845 |
| Androderm | 16 | $16,516 | $1,032 |
| Humalog | 19 | $8,102 | $426 |
| Humalog Kwikpen U-100 | 25 | $7,070 | $283 |
| Testosterone | 27 | $5,547 | $205 |
| Methimazole | 162 | $3,101 | $19 |
| Lantus | 11 | $2,637 | $240 |
| Levothyroxine | 95 | $2,164 | $23 |
| Lantus Solostar | 12 | $1,967 | $164 |
| Hydrocortisone | 22 | $1,694 | $77 |
| Ultra-Fine Nano Pen Needle | 24 | $839 | $35 |
| Cabergoline | 17 | $755 | $44 |
| Ultra-Fine Short Pen Needle | 22 | $600 | $27 |
| Alendronate | 47 | $489 | $10 |
| Acarbose | 11 | $477 | $43 |
| Risedronate | 14 | $269 | $19 |
2021: 15 drugs
| Forteo | 65 | $180,367 | $2,775 |
| Androderm | 20 | $24,341 | $1,217 |
| Victoza 2-Pak | 15 | $16,238 | $1,083 |
| Lantus | 27 | $10,576 | $392 |
| Testosterone | 31 | $7,043 | $227 |
| Humalog | 13 | $6,580 | $506 |
| Humalog Kwikpen U-100 | 13 | $3,731 | $287 |
| Methimazole | 145 | $3,056 | $21 |
| Levothyroxine | 87 | $2,049 | $24 |
| Hydrocortisone | 18 | $1,520 | $84 |
| Ultra-Fine Short Pen Needle | 37 | $942 | $25 |
| Alendronate | 76 | $786 | $10 |
| Cabergoline | 13 | $735 | $57 |
| Ultra-Fine Nano Pen Needle | 15 | $466 | $31 |
| Risedronate | 15 | $266 | $18 |
2020: 9 drugs
| Forteo | 22 | $55,815 | $2,537 |
| Androderm | 22 | $22,270 | $1,012 |
| Humalog | 23 | $8,950 | $389 |
| Lantus | 18 | $8,872 | $493 |
| Testosterone | 21 | $7,712 | $367 |
| Levothyroxine | 72 | $1,858 | $26 |
| Methimazole | 65 | $1,556 | $24 |
| Alendronate | 49 | $547 | $11 |
| Ultra-Fine Short Pen Needle | 11 | $152 | $14 |
2019: 5 drugs
| Forteo | 15 | $36,754 | $2,450 |
| Androderm | 11 | $7,372 | $670 |
| Levothyroxine | 59 | $1,622 | $27 |
| Methimazole | 35 | $666 | $19 |
| Alendronate | 38 | $417 | $11 |
2018: 4 drugs
| Levothyroxine | 25 | $395 | $16 |
| Methimazole | 26 | $293 | $11 |
| Trueplus Insulin | 11 | $158 | $14 |
| Metoprolol | 12 | $130 | $11 |
2016: 1 drug
| Omeprazole | 11 | $390 | $35 |
2015: 1 drug
| Levothyroxine | 16 | $227 | $14 |
2014: 2 drugs
| Atorvastatin | 13 | $406 | $31 |
| Lisinopril | 18 | $113 | $6 |
Money from drug and device companies
$43 in 2025
| 2025 | 1 | 1 | None | $43 |
| 2023 | 1 | 1 | None | $131 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Harmony Biosciences | Wakix | $43 | 1 payment
|
See the published payment
| Harmony Biosciences | Meals · 2025-03-04 | Wakix | $43 |
See earlier years (2023)
2023: $131
| Sanofi-Aventis U.S. | Tzield | $131 | 1 payment
|
Professional record
- NPI
- 1700227873
- Licence
- CA A154935California A154935: Current · expires 2027-05-31
- Trained
- R Franklin University of Med & Sci/Chicago Medical School, 2013
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RE0101X (207RE0101X)
- Mailing address
- 275 Hospital Pkwy Ste 600, San Jose, CA, 95119
- NPI first listed
- 2013-07-17
- NPI last updated
- 2022-01-11
- NPI record certified
- 2020-12-10
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2650 Ridge Ave, Evanston, IL, 60201 · 275 Hospital Pkwy, San Jose, CA, 95119 · 275 Hospital Pkwy Ste 600, San Jose, CA, 95119
This office lists an electronic records connection.